Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries

Fig. 6

Scenario analysis: the efficacy of the interventions and its impact on the optimal strategy. The optimal strategy is indicated by the colours (the current strategy is no intervention), and our certainty is indicated by the sizes of the markers. Countries are ranked by RSV incidence rate (ordered from high to low on the left Y-axis [incidence per 1000 person-year in brackets]) and stratified by income group (LIC or LMIC, on the right Y-axis)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us